Harvard chemists hope to shorten time and difficulty in measuring effectiveness and potential of new compounds

Two Harvard-trained researchers, who bonded while battling epidemics in West Africa, are developing diagnostic technology to help women monitor their own health and fertility.

Research alliance will advance small-molecule therapy for most common form of acute leukemia, targeting proteins involved in transcriptional regulation.

With subtypes now defined, future studies could reveal previously unknown contributions of the serotonergic neuronal system to disease, inform the development of biomarkers, or lead to more targeted therapies.